CN103109190B - 用于测量结合治疗性单克隆抗体的抗体的测定法 - Google Patents

用于测量结合治疗性单克隆抗体的抗体的测定法 Download PDF

Info

Publication number
CN103109190B
CN103109190B CN201180042537.9A CN201180042537A CN103109190B CN 103109190 B CN103109190 B CN 103109190B CN 201180042537 A CN201180042537 A CN 201180042537A CN 103109190 B CN103109190 B CN 103109190B
Authority
CN
China
Prior art keywords
tmab
antibody
monoclonal antibody
antibodies
sample
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN201180042537.9A
Other languages
English (en)
Chinese (zh)
Other versions
CN103109190A (zh
Inventor
V.P.格鲁纳特
U.克劳斯
P.库巴莱克
M.罗思福斯
B.厄普梅尔
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of CN103109190A publication Critical patent/CN103109190A/zh
Application granted granted Critical
Publication of CN103109190B publication Critical patent/CN103109190B/zh
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854—Immunoglobulins
    • C—CHEMISTRY; METALLURGY
    • C40—COMBINATORIAL TECHNOLOGY
    • C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
    • C40B30/00—Methods of screening libraries
    • C40B30/04—Methods of screening libraries by measuring the ability to specifically bind a target molecule, e.g. antibody-antigen binding, receptor-ligand binding
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/52—Predicting or monitoring the response to treatment, e.g. for selection of therapy based on assay results in personalised medicine; Prognosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
CN201180042537.9A 2010-08-19 2011-08-17 用于测量结合治疗性单克隆抗体的抗体的测定法 Active CN103109190B (zh)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP10173408.5 2010-08-19
EP10173408 2010-08-19
PCT/EP2011/064178 WO2012022774A1 (en) 2010-08-19 2011-08-17 An assay for measurement of antibodies binding to a therapeutic monoclonal antibody

Publications (2)

Publication Number Publication Date
CN103109190A CN103109190A (zh) 2013-05-15
CN103109190B true CN103109190B (zh) 2015-07-22

Family

ID=42727619

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201180042537.9A Active CN103109190B (zh) 2010-08-19 2011-08-17 用于测量结合治疗性单克隆抗体的抗体的测定法

Country Status (7)

Country Link
US (1) US9081016B2 (enExample)
EP (1) EP2606362B1 (enExample)
JP (1) JP5805190B2 (enExample)
CN (1) CN103109190B (enExample)
CA (1) CA2802278A1 (enExample)
ES (1) ES2555864T3 (enExample)
WO (1) WO2012022774A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104614535B (zh) * 2015-02-10 2017-11-28 深圳市新产业生物医学工程股份有限公司 甲状腺微粒体抗体检测试剂盒及其制备方法和应用
EP3482199A1 (en) * 2016-07-08 2019-05-15 Atonomics A/S A universal assay for determining the quantity of therapeutic monoclonal antibodies and their corresponding anti-drug-antibodies in samples
CN106093413A (zh) * 2016-07-18 2016-11-09 本·沙朗 一种抗英夫利西抗体elisa检测试剂盒和检测方法
US11698367B2 (en) * 2017-09-15 2023-07-11 Beckman Coulter, Inc. Flow based assays for therapeutics
WO2019191280A1 (en) * 2018-03-27 2019-10-03 Laboratory Corporation Of America Holdings Sandwich elisa for identifying subjects who may benefit from treatment with therapeutic agents
JP7570421B2 (ja) * 2020-01-02 2024-10-21 エフ． ホフマン－ラ ロシュ アーゲー Ａｄａ応答特定アッセイ
CN115552244A (zh) * 2020-05-08 2022-12-30 豪夫迈·罗氏有限公司 用于高药物耐受性测试的高离子强度解离测定
CN117590002B (zh) * 2023-11-23 2024-10-22 上海领检科技有限公司 一种TNFα抗药抗体的检测方法及检测试剂盒

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1766621A (zh) * 2004-10-30 2006-05-03 霍夫曼-拉罗奇有限公司 在检测已经以抗原－特异性方式结合的特定免疫球蛋白类型的抗体时降低阵列测试形式中空白值的免疫复合物特异性抗体
WO2009003082A2 (en) * 2007-06-26 2008-12-31 Vanderbilt University Immunological compositions as cancer biomarkers and/or therapeutics
CN101437536A (zh) * 2006-03-23 2009-05-20 诺华有限公司 抗肿瘤细胞抗原抗体治疗
CN101646449A (zh) * 2006-10-10 2010-02-10 斯奎科公司 用于治疗和诊断癌症的组合物和方法

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1508132A (en) 1974-05-20 1978-04-19 Technicon Instr Analysis of biological fluids
US5219730A (en) 1982-09-28 1993-06-15 New York University Idiotype-anti-idiotype immunoassay
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4554088A (en) 1983-05-12 1985-11-19 Advanced Magnetics Inc. Magnetic particles for use in separations
US4628037A (en) 1983-05-12 1986-12-09 Advanced Magnetics, Inc. Binding assays employing magnetic particles
US4695393A (en) 1983-05-12 1987-09-22 Advanced Magnetics Inc. Magnetic particles for use in separations
US4698302A (en) 1983-05-12 1987-10-06 Advanced Magnetics, Inc. Enzymatic reactions using magnetic particles
US4828981A (en) 1983-08-24 1989-05-09 Synbiotics Corporation Immunoassays for determining Dirofilaria immitis infection using antiidiotype monoclonal antibody reagents
EP0170302A1 (fr) 1984-06-27 1986-02-05 l'Association internationale à but scientifique, dite: Institut international de pathologie cellulaire et moléculaire Procédé de dosage immunologique d'une substance dans un échantillon liquide au moyen d'anticorps anti-idiotypiques
US5238808A (en) 1984-10-31 1993-08-24 Igen, Inc. Luminescent metal chelate labels and means for detection
JPH0823558B2 (ja) 1984-11-27 1996-03-06 オ−ジエニクス リミテツド 検定装置
DE3689645D1 (de) 1985-10-16 1994-03-24 Fresenius Ag Selektives Adsorbens zur Bindung von Immunkomplexen.
EP0243471A4 (en) 1985-10-22 1989-07-11 Cooper Lipotech Inc SOLID PHASE LIPOSOME IMMUNOANALYSIS SYSTEM.
US6316607B1 (en) 1986-04-30 2001-11-13 Igen International, Inc. Electrochemiluminescent assays
US4965392A (en) 1987-03-26 1990-10-23 Neorx Corporation Chelating compounds for metal-radionuclide labeled proteins
US5935779A (en) 1988-11-03 1999-08-10 Igen International Inc. Methods for improved particle electrochemiluminescence assay
GB8803000D0 (en) 1988-02-10 1988-03-09 Ekins Roger Philip Determination of ambient concentrations of several analytes
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
KR0143993B1 (ko) 1988-11-03 1998-07-15 리차아드 제이 매씨이 전기화학 발광성 분석
US5068088A (en) 1988-11-03 1991-11-26 Igen, Inc. Method and apparatus for conducting electrochemiluminescent measurements
WO1990006515A1 (en) 1988-12-09 1990-06-14 Centocor, Inc. Anti-idiotopic immunometric assay
DE3920358A1 (de) 1989-06-22 1991-01-17 Behringwerke Ag Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
US5661016A (en) 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
KR100272077B1 (ko) 1990-08-29 2000-11-15 젠팜인터내셔날,인코포레이티드 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물
US5625126A (en) 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5364930A (en) 1990-10-16 1994-11-15 Northwestern University Synthetic C1q peptide fragments
WO1992009690A2 (en) 1990-12-03 1992-06-11 Genentech, Inc. Enrichment method for variant proteins with altered binding properties
IL100866A (en) 1991-02-06 1995-10-31 Igen Inc Method and apparatus for magnetic microparticulate based luminescence assay including plurality of magnets
WO1993008472A1 (en) 1991-10-15 1993-04-29 Multilyte Limited Binding assay employing labelled reagent
AU3178993A (en) 1991-11-25 1993-06-28 Enzon, Inc. Multivalent antigen-binding proteins
US5466416A (en) 1993-05-14 1995-11-14 Ghaed; Ali Apparatus and methods for carrying out electrochemiluminescence test measurements
US6241963B1 (en) 1995-10-19 2001-06-05 The Trustees Of The University Of Pennsylvania Dopamine and serotonin transporter ligands and imaging agents
DE19806989A1 (de) 1998-02-19 1999-08-26 Roche Diagnostics Gmbh Erzeugung räumlich scharf begrenzter Festphasen für Bindungsassays
IT1315254B1 (it) 1999-11-05 2003-02-03 Diesse Diagnostica Senese Spa Metodo per la determinazione qualitativa e quantitativa di anticorpiumani di classe igc.
DE60025526T2 (de) 1999-11-16 2006-08-24 Genentech, Inc., South San Francisco Elisa für vegf
US20050130246A1 (en) 2003-10-27 2005-06-16 Hossein Salimi-Moosavi Detecting human anti-therapeutic antibodies
DK2645106T4 (da) 2005-04-04 2024-12-02 Biogen Ma Inc Fremgangsmåder til evaluering af et immunrespons på et terapeutisk middel

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1766621A (zh) * 2004-10-30 2006-05-03 霍夫曼-拉罗奇有限公司 在检测已经以抗原－特异性方式结合的特定免疫球蛋白类型的抗体时降低阵列测试形式中空白值的免疫复合物特异性抗体
EP1653233A1 (en) * 2004-10-30 2006-05-03 Roche Diagnostics GmbH Method for determining antibodies of a particular class using an immune complex-specific antibody
CN101437536A (zh) * 2006-03-23 2009-05-20 诺华有限公司 抗肿瘤细胞抗原抗体治疗
CN101646449A (zh) * 2006-10-10 2010-02-10 斯奎科公司 用于治疗和诊断癌症的组合物和方法
WO2009003082A2 (en) * 2007-06-26 2008-12-31 Vanderbilt University Immunological compositions as cancer biomarkers and/or therapeutics

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
THE IMMUNOGENICITY OF THE 7E3 MURINE MONOCLONAL FAB ANTIBODY FRAGMENT VARIABLE REGION IS DRAMATICALLY REDUCED IN HUMANS BY SUBSTITUTION OF HUMAN FOR MURINE CONSTANT REGIONS;DAVID M. KNIGHT等;《Molecular Immunology》;19951231;第32卷(第16期);第1273页右栏倒数第1段，第1274页左栏第1段 *

Also Published As

Publication number Publication date
EP2606362B1 (en) 2015-09-30
EP2606362A1 (en) 2013-06-26
CN103109190A (zh) 2013-05-15
US9081016B2 (en) 2015-07-14
HK1180767A1 (en) 2013-10-25
US20130157892A1 (en) 2013-06-20
CA2802278A1 (en) 2012-02-23
ES2555864T3 (es) 2016-01-11
JP2013536419A (ja) 2013-09-19
JP5805190B2 (ja) 2015-11-04
WO2012022774A1 (en) 2012-02-23

Similar Documents

Publication Publication Date Title
CN103109190B (zh) 用于测量结合治疗性单克隆抗体的抗体的测定法
CN112384808B (zh) 用于减轻抗药物抗体（ada）免疫测定中的药物靶标干扰的方法
JP5786020B2 (ja) 関節リウマチを診断する方法および試薬
CN102884433A (zh) 用于检测抗体的方法
US20040229284A1 (en) Multiplex analysis of proteins
CN100593721C (zh) 用于病人的样本中生物化学标记物的早期和同步检测的免疫测定法和试剂盒
KR101866844B1 (ko) 면역분석에서 시약의 반응성을 조절하기 위한 공동 결합
JPWO2016136863A1 (ja) Ｌ−ｆａｂｐの免疫学的測定方法及び該方法に用いられる測定試薬
US20120190563A1 (en) Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor
JP7431226B2 (ja) レンバチニブ及びエベロリムスを含む併用療法のためのバイオマーカー
US20120115745A1 (en) Methods for predicting sensitivity to treatment with a targeted tyrosine kinase inhibitor
JP2013525814A (ja) 標的化チロシンキナーゼインヒビターでの治療に対する感受性の予測方法
KR20180013878A (ko) 렌바티닙 및 에베로리무스를 포함하는 병용 요법을 위한 생체표지
HK1180767B (en) An assay for measurement of antibodies binding to a therapeutic monoclonal antibody
JP5456056B2 (ja) 体液中のｉｆｉ１６の検出
JP5750646B2 (ja) Ｓｃｃａ２濃度測定によるアレルギー疾患の検査方法
WO2017033846A1 (ja) 免疫試験方法および免疫試験キット
JP5750645B2 (ja) アレルギー疾患の検査方法

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 1180767

Country of ref document: HK

C14 Grant of patent or utility model
GR01 Patent grant
REG Reference to a national code

Ref country code: HK

Ref legal event code: GR

Ref document number: 1180767

Country of ref document: HK